We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-0.56%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
-$1.33B
(-7.8%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
173
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$70.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$66.5M |
| 3 |
Becton Dickinson
BDX
|
+$61.6M |
| 4 |
GitLab
GTLB
|
+$58.7M |
| 5 |
Teradyne
TER
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$85.2M |
| 2 |
Steris
STE
|
+$78.2M |
| 3 |
CVS Health
CVS
|
+$62.9M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$61.9M |
| 5 |
FIVE9
FIVN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.08% |
| 2 | Industrials | 22.24% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Aflac
AFL
$58.7B
| $32.3M | 0.21% |
575,000
| – | – |
|
102
Merit Medical Systems
MMSI
$5.2B
| $31.8M | 0.2% |
563,251
| – | – |
|
103
First Solar
FSLR
$22.3B
| $31.8M | 0.2% |
240,184
+233,100
| +3,291% | +$25M |
|
104
Harmony Biosciences
HRMY
$2.42B
| $31.4M | 0.2% |
709,325
-122,000
| -15% | -$5.95M |
|
105
Exelixis
EXEL
$13.9B
| $31M | 0.2% |
1,975,274
-334,025
| -14% | -$6.45M |
|
106
Power Integrations
POWI
$2.92B
| $31M | 0.2% |
481,435
-299,117
| -38% | -$22.4M |
|
107
Insmed
INSM
$27.4B
| $30M | 0.19% |
1,391,349
+759,500
| +120% | +$18.2M |
|
108
RLI Corp
RLI
$5.63B
| $28.7M | 0.18% |
560,000
| – | – |
|
109
MongoDB
MDB
$30.8B
| $28.4M | 0.18% |
142,885
-177,691
| -55% | -$51.9M |
|
110
Alkermes
ALKS
$7.69B
| $28.3M | 0.18% |
+1,267,196
| New | +$33M |
|
|
ITCI
111
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $28.1M | 0.18% |
604,250
-284,287
| -32% | -$14.9M |
|
112
Hagerty
HGTY
$1.51B
| $27M | 0.17% |
3,000,000
+1,964,748
| +190% | +$22.2M |
|
113
Supernus Pharmaceuticals
SUPN
$2.41B
| $26.9M | 0.17% |
794,120
| – | – |
|
114
T-Mobile US
TMUS
$196B
| $26.8M | 0.17% |
200,058
-101,766
| -34% | -$14.3M |
|
115
Linde
LIN
$214B
| $26.3M | 0.17% |
75,817
-3,423
| -4% | -$983K |
|
116
United Rentals
URI
$61.6B
| $25.9M | 0.17% |
95,934
-12,165
| -11% | -$3.54M |
|
117
Kornit Digital
KRNT
$690M
| $25.1M | 0.16% |
942,023
-219,544
| -19% | -$6.32M |
|
118
Arcutis Biotherapeutics
ARQT
$3.05B
| $25M | 0.16% |
1,309,268
-96,528
| -7% | -$2.19M |
|
119
Bank of America
BAC
$416B
| $24.9M | 0.16% |
824,241
-59,809
| -7% | -$2M |
|
120
Mirum Pharmaceuticals
MIRM
$6.28B
| $24.8M | 0.16% |
1,179,907
-32,525
| -3% | -$783K |
|
|
DAWN
121
DELISTED
Day One Biopharmaceuticals
DAWN
| $24.7M | 0.16% |
1,235,575
+263,879
| +27% | +$5.61M |
|
122
James River Group Holdings
JRVR
$183M
| $24.5M | 0.16% |
1,075,000
+150,000
| +16% | +$3.58M |
|
123
JPMorgan Chase
JPM
$931B
| $24.1M | 0.15% |
230,204
+14,486
| +7% | +$1.66M |
|
124
US Foods
USFD
$20.5B
| $23.9M | 0.15% |
902,544
-6,319
| -0.7% | -$196K |
|
125
Elevance Health
ELV
$90.8B
| $23.2M | 0.15% |
51,049
+1,205
| +2% | +$577K |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q3 2022 Portfolio in Review
As of Q3 2022, Polar Capital Holdings held 471 positions worth $15.7B, down 7.8% from $17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings's Q3 2022 filing shows 38 new, 139 increased, 173 reduced and 54 closed positions. Its largest new stake was DexCom: 834,956 shares worth $67.2M. The largest sale was Adobe, an estimated $85.2M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
- Polar Capital Holdings's largest Q3 2022 buy was DexCom: 834,956 shares worth $67.2M.
- Polar Capital Holdings added most to Meta Platforms (Facebook) in Q3 2022, an estimated $66.5M increase.
- Polar Capital Holdings's biggest Q3 2022 reduction was Neurocrine Biosciences, cutting an estimated $61.9M.
- Polar Capital Holdings fully exited Adobe in Q3 2022, selling an estimated $85.2M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $15.7B portfolio in Q3 2022.
- Polar Capital Holdings opened 38 new positions and closed 54 in Q3 2022.
- Polar Capital Holdings's portfolio value fell 7.8% quarter-over-quarter to $15.7B.
Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.